Cents, thanks for sharing your DD on stemvacs vaccine. Considering the only one company that received go ahead for clinical phase I trial was gobbled up by Bausch Health on 2015 for 495 million that leaves only TSOI as sole player in the market ready for buy out by BIG PHARMA who want to increase their exposure in cancer trials (as u know there are plenty some to throw 500 million ) to dramatically expedite their drug approval process.